BION Modernizes Dialysis Technical Operations to Improve Patient Care

From dialysis center design through facility and home maintenance BION maximizes efficiency, saving valuable time and money while ensuring physician, clinician, and patient satisfaction

BION (formerly Biomedix Dialysis) has reimagined the world of dialysis technical operations, providing efficient, cost effective strategies to maintain dialysis equipment, nationwide. BION employs and manages teams of experienced biomedical care experts exclusively focused on dialysis equipment.

Focused experience yields highly skilled Biomeds with the expertise to quickly solve any issues that arise, and seamlessly collaborate with clinical staff to deliver world-class patient care.

BION provides support for all dialysis care settings; hospitals, skilled nursing facilities, outpatient treatment centers, and home therapies.

“We recently launched another staff assisted home hemodialysis dialysis program, within a nursing home in the Philadelphia market, in an effort to provide residents with care in a setting that they are most comfortable,” said Compass Home Dialysys’ Chief Operating Officer, Jeremy Graves. “Using BION’s Biomed team to run our technical department is not only cost effective, but the real value is their support services ensure we are operating at peak performance at all times, so our clinicians can provide the optimal experience that we want for dialysis residents.”

Supply chain has become increasingly complex, with multiple partners being instrumental in the effective operation of dialysis equipment. As part of the customer commitment the BION team fosters well established relationships with leading industry suppliers to procure the needed supplies in a timely manner while keeping costs down.

“BION was the catalyst for the successful completion of Serenity Blue Dialysis Care,” said Serenity Blue Executive Director Ester Mbaya. “At the onset of the project, they guided the design and layout of the clinic helping us create a beautiful and functional space for healing. It was evident through the coordination of the construction, vendors, and logistics, they were prepared for every issue that could arise. We would not be where we are today without their professional support and candor. I am so grateful they are a part of the Serenity Blue family.”

BION’s support services include center design and home assessments, installation, independent technical audits and survey-readiness, preventative maintenance and safety testing, repairs, calibrations, system cleaning and disinfection, system swaps and manufacturer upgrades, and ancillary equipment services. Maintenance management is made easy through use of an industry-leading technical operations app, developed by BION’s leadership team, learn more.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”